|
122 Companies |
|
196 Products |
|
196 Products |
|
116 Mechanisms of Action |
|
3 Trials |
|
2338 News |
|
| «12...1011121314151617181920...4647» |
- haloperidol / Generic mfg.
Trial completion, Enrollment change: PMD: Pharmacological Management of Delirium (clinicaltrials.gov) - Aug 29, 2015
P=N/A, N=551, Completed, Sponsor: Indiana University
Recruiting --> Completed | N=876 --> 551
- haloperidol / Generic mfg.
Enrollment closed, Trial primary completion date: PE-POD: Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy (clinicaltrials.gov) - Aug 28, 2015
P4, N=200, Active, not recruiting, Sponsor: Indiana University
Recruiting --> Completed | N=876 --> 551 Recruiting --> Active, not recruiting | Trial primary completion date: May 2015 --> Dec 2015
- Enrollment change, Trial withdrawal: Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease (clinicaltrials.gov) - Aug 25, 2015
P3, N=0, Withdrawn, Sponsor: Medical College of Wisconsin
Recruiting --> Active, not recruiting | Trial primary completion date: May 2015 --> Dec 2015 N=50 --> 0 | Not yet recruiting --> Withdrawn
- Trial primary completion date: NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment (clinicaltrials.gov) - Aug 22, 2015
P2, N=50, Recruiting, Sponsor: Chang Gung Memorial Hospital
N=50 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Oct 2014 --> Jul 2016
- Trial primary completion date, Metastases: The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study (clinicaltrials.gov) - Aug 22, 2015
P2, N=60, Recruiting, Sponsor: Bruyere Research Institute
Trial primary completion date: Oct 2014 --> Jul 2016 Trial primary completion date: Aug 2015 --> Dec 2015
- Trial primary completion date: Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=15, Recruiting, Sponsor: University of Kansas
Trial primary completion date: Aug 2015 --> Dec 2015 Trial primary completion date: Dec 2015 --> Dec 2017
- Trial primary completion date: DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia (clinicaltrials.gov) - Aug 22, 2015
P2, N=90, Recruiting, Sponsor: Chang Gung Memorial Hospital
Trial primary completion date: Dec 2015 --> Dec 2017 Trial primary completion date: Sep 2015 --> Sep 2016
- Trial primary completion date: Study to Evaluate Coconut Oil for Alzheimer's Disease (clinicaltrials.gov) - Aug 20, 2015
P2/3, N=65, Recruiting, Sponsor: University of South Florida
Trial primary completion date: Sep 2015 --> Sep 2016 Trial primary completion date: Jun 2015 --> Dec 2015
- || Trial primary completion date: COGHIC-AV45: Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage (clinicaltrials.gov) - Aug 20, 2015
P=N/A, N=70, Recruiting, Sponsor: University Hospital, Toulouse
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Jul 2015 --> Dec 2015
- Trial completion: MAPRCT: Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=55, Completed, Sponsor: National University, Singapore
Trial primary completion date: Jul 2015 --> Dec 2015 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia (Allena-Mente). (clinicaltrials.gov) - Aug 17, 2015
P2, N=121, Completed, Sponsor: Fondazione Golgi Cenci
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Mar 2015
- Enrollment change, Trial termination: EPAC-M: Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient (clinicaltrials.gov) - Aug 15, 2015
P=N/A, N=5, Terminated, Sponsor: Centre Hospitalier Universitaire de Nice
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Mar 2015 N=36 --> 5 | Recruiting --> Terminated
- || Trial primary completion date: Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis (clinicaltrials.gov) - Aug 14, 2015
P2, N=158, Recruiting, Sponsor: University of Miami
N=36 --> 5 | Recruiting --> Terminated Trial primary completion date: Aug 2015 --> Dec 2016
- | Trial primary completion date: Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART) (clinicaltrials.gov) - Aug 14, 2015
P3, N=50, Active, not recruiting, Sponsor: Seoul National University Bundang Hospital
Trial primary completion date: Aug 2015 --> Dec 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- olanzapine / Generic mfg., tetrabenazine / Generic mfg.
Trial primary completion date: NEUROHD: Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride (clinicaltrials.gov) - Aug 14, 2015
P3, N=180, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Mar 2015 --> Mar 2016
- || donepezil / Generic mfg.
Trial initiation date: A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=6660, Recruiting, Sponsor: Eisai Korea Inc.
Trial primary completion date: Mar 2015 --> Mar 2016 Initiation date: Feb 2014 --> Mar 2015
- Trial primary completion date: CONCEPT: Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Impairment in Cancer Patients (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=125, Recruiting, Sponsor: General Hospital Groeninge
Initiation date: Feb 2014 --> Mar 2015 Trial primary completion date: Jun 2015 --> Sep 2015
- Trial primary completion date: COST-TBI: Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury (clinicaltrials.gov) - Aug 13, 2015
P1/2, N=24, Recruiting, Sponsor: Boston Medical Center
Trial primary completion date: Jun 2015 --> Sep 2015 Trial primary completion date: May 2016 --> May 2017
- Trial primary completion date: GRECogVASC: Post-stroke Cognitive Impairment and Dementia (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=302, Recruiting, Sponsor: Centre Hospitalier Universitaire, Amiens
Trial primary completion date: May 2016 --> May 2017 Trial primary completion date: Aug 2013 --> Dec 2016
- Trial initiation date, Trial primary completion date: Actigraphy to MEasuRe Intensive Care Unit Activity (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=75, Recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Aug 2013 --> Dec 2016 Initiation date: Oct 2014 --> Jul 2015 | Trial primary completion date: Sep 2015 --> Dec 2015
- | Targretin oral (bexarotene oral) / ReXceptor
Trial completion, Trial initiation date: A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects (clinicaltrials.gov) - Aug 13, 2015
P1, N=12, Completed, Sponsor: ReXceptor, Inc.
Initiation date: Oct 2014 --> Jul 2015 | Trial primary completion date: Sep 2015 --> Dec 2015 Not yet recruiting --> Completed | Initiation date: Feb 2014 --> Aug 2014
- dexmedetomidine / Generic mfg.
Surgery: A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery (clinicaltrials.gov) - Aug 13, 2015
P3, N=0, Withdrawn, Sponsor: Hospira, Inc.
Not yet recruiting --> Completed | Initiation date: Feb 2014 --> Aug 2014 N=304 --> 0 | Terminated --> Withdrawn
- | dexmedetomidine / Generic mfg.
Surgery: A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery (clinicaltrials.gov) - Aug 13, 2015
P3, N=52, Terminated, Sponsor: Hospira, Inc.
N=304 --> 0 | Terminated --> Withdrawn N=310 --> 52
- Enrollment change, Trial initiation date, Trial primary completion date: Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment. (clinicaltrials.gov) - Aug 13, 2015
P2, N=215, Completed, Sponsor: National Institute of Mental Health (NIMH)
N=310 --> 52 N=143 --> 215 | Initiation date: Jan 2000 --> Jan 1990 | Trial primary completion date: Aug 2013 --> Aug 1996
- ||| Trial completion, Trial primary completion date: PARTAGE: Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=1130, Completed, Sponsor: Central Hospital, Nancy, France
N=143 --> 215 | Initiation date: Jan 2000 --> Jan 1990 | Trial primary completion date: Aug 2013 --> Aug 1996 Active, not recruiting --> Completed | Trial primary completion date: Dec 2010 --> Dec 2013
- pioglitazone / Generic mfg.
Trial completion, Enrollment change: Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors (clinicaltrials.gov) - Aug 12, 2015
P1, N=18, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2010 --> Dec 2013 Active, not recruiting --> Completed | N=100 --> 18
- | Enrollment open: CBTAC: Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers (clinicaltrials.gov) - Aug 12, 2015
P2, N=50, Recruiting, Sponsor: University of Zurich
Active, not recruiting --> Completed | N=100 --> 18 Active, not recruiting --> Recruiting
- Trial completion, Enrollment change: JAZ-TOP: What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate? (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=77, Completed, Sponsor: Central Hospital, Nancy, France
Active, not recruiting --> Recruiting Recruiting --> Completed | N=60 --> 77
- Trial completion: 2-STEP: Thinking, Walking Outcomes by Type of Exercise (clinicaltrials.gov) - Aug 12, 2015
P2, N=22, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed | N=60 --> 77 Recruiting --> Completed
- isoflurane / Generic mfg.
Trial completion: MAD-PIA: Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia (clinicaltrials.gov) - Aug 12, 2015
P1, N=105, Completed, Sponsor: Duke University
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed, Trial primary completion date: VENUS: Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus (clinicaltrials.gov) - Aug 11, 2015
P4, N=300, Active, not recruiting, Sponsor: University of Science Malaysia
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Sep 2015
- isoflurane / Generic mfg.
Enrollment closed, Trial primary completion date: Reconstructing Consciousness and Cognition (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=60, Active, not recruiting, Sponsor: University of Michigan
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Jul 2016
- Biomarker: Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=60, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Sep 2016
- | Enrollment open, Trial initiation date, Trial primary completion date: Brain-Computer Interface System for Training Memory and Attention in Elderly (clinicaltrials.gov) - Aug 11, 2015
P2/3, N=240, Recruiting, Sponsor: Duke-NUS Graduate Medical School
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Sep 2016 Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Jul 2015 | Trial primary completion date: Dec 2016 --> Jul 2016
- Enrollment closed: Computer-based Cognitive Training for Individuals With Parkinson's Disease (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Virginia Commonwealth University
Not yet recruiting --> Recruiting | Initiation date: Feb 2015 --> Jul 2015 | Trial primary completion date: Dec 2016 --> Jul 2016 Recruiting --> Active, not recruiting
- Trial completion, Enrollment change: The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury (clinicaltrials.gov) - Aug 6, 2015
P3, N=20, Completed, Sponsor: Brock University
Recruiting --> Active, not recruiting Recruiting --> Completed | N=15 --> 20
- || donepezil / Generic mfg.
Enrollment closed, Enrollment change: A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS) (clinicaltrials.gov) - Aug 5, 2015
P=N/A, N=536, Active, not recruiting, Sponsor: Eisai Korea Inc.
Recruiting --> Completed | N=15 --> 20 Recruiting --> Active, not recruiting | N=700 --> 536
- | Trial completion: Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia (clinicaltrials.gov) - Aug 1, 2015
P3, N=64, Completed, Sponsor: Ki Woong Kim
Recruiting --> Active, not recruiting | N=700 --> 536 Active, not recruiting --> Completed
- atorvastatin / Generic mfg.
Trial primary completion date: Modulation of Monocyte Activation by Atorvastatin in HIV Infection (clinicaltrials.gov) - Jul 17, 2015
P4, N=15, Active, not recruiting, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Dec 2015
- || PF-05212377 / Pfizer
Trial primary completion date: Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil (clinicaltrials.gov) - Jul 16, 2015
P2, N=342, Recruiting, Sponsor: Pfizer
Trial primary completion date: Jun 2014 --> Dec 2015 Trial primary completion date: Dec 2016 --> Sep 2015
- Trial completion, Enrollment change, Trial primary completion date: SID: Study of Sleep and Delirium in the Intensive Care Unit (ICU) (clinicaltrials.gov) - Jul 15, 2015
P=N/A, N=57, Completed, Sponsor: University of California, San Francisco
Trial primary completion date: Dec 2016 --> Sep 2015 Recruiting --> Completed | N=100 --> 57 | Trial primary completion date: Dec 2014 --> Nov 2012
- Phase classification: MAIN: Memory and Insulin in Early Alzheimer's Disease (clinicaltrials.gov) - Jul 14, 2015
P1/2, N=31, Completed, Sponsor: Jeff Burns, MD
Recruiting --> Completed | N=100 --> 57 | Trial primary completion date: Dec 2014 --> Nov 2012 Phase classification: P2 --> P1/2
- Trial primary completion date: A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment (clinicaltrials.gov) - Jul 13, 2015
P=N/A, N=100, Recruiting, Sponsor: Palo Alto Veterans Institute for Research
Phase classification: P2 --> P1/2 Trial primary completion date: Sep 2014 --> Jan 2016
- Enrollment change: Effect of Raised CBF During CEA on Cognition in DM Patients (clinicaltrials.gov) - Jul 13, 2015
P=N/A, N=10, Terminated, Sponsor: Columbia University
Trial primary completion date: Sep 2014 --> Jan 2016 N=20 --> 10
- GSK2981710 / GSK
Trial completion, Enrollment change, Trial primary completion date: Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects (clinicaltrials.gov) - Jul 13, 2015
P1, N=33, Completed, Sponsor: GlaxoSmithKline
N=20 --> 10 Recruiting --> Completed | N=88 --> 33 | Trial primary completion date: Oct 2015 --> Jul 2015
- Enrollment closed, Surgery: The Delirium-CS Canada Study (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=234, Active, not recruiting, Sponsor: St. Boniface General Hospital Research Centre
Recruiting --> Completed | N=88 --> 33 | Trial primary completion date: Oct 2015 --> Jul 2015 Completed --> Active, not recruiting
- | Enrollment change: CBTAC: Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers (clinicaltrials.gov) - Jul 9, 2015
P2, N=50, Active, not recruiting, Sponsor: University of Zurich
Completed --> Active, not recruiting N=124 --> 50
- Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date: Mental Health and Cognitive Dysfunction: A Multicenter Study at Pediatric Rehabilitation Clinics in North Norway (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=320, Recruiting, Sponsor: University Hospital of North Norway
N=124 --> 50 Not yet recruiting --> Recruiting | N=100 --> 320 | Initiation date: Jan 2013 --> Oct 2012 | Trial primary completion date: Dec 2013 --> Jun 2016
- || Biomarker, Trial primary completion date: ADDM: Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=60, Enrolling by invitation, Sponsor: University of Eastern Finland
Not yet recruiting --> Recruiting | N=100 --> 320 | Initiation date: Jan 2013 --> Oct 2012 | Trial primary completion date: Dec 2013 --> Jun 2016 Trial primary completion date: Nov 2014 --> Sep 2015
- Trial primary completion date: CAPHA: Central Auditory Processing and the Use of Hearing Aids (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=56, Recruiting, Sponsor: Jong Woo Chung
Trial primary completion date: Nov 2014 --> Sep 2015 Trial primary completion date: Apr 2015 --> Sep 2015